Metropolitan Life Insurance Company (MetLife)’s Aemetis AMTX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AMTX Stock Details AMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,851	Closed	-$7.33K	–	2317
2022 Q4	$7.33K	Buy	1,851 +77	+4%	+$437	﹤0.01%	2341
2022 Q3	$10.9K	Buy	+1,774	New	+$13.5K	﹤0.01%	2276
2022 Q2	–	Sell	-1,740	Closed	-$22K	–	2374
2022 Q1	$22K	Sell	1,740 -5,562	-76%	-$61.3K	﹤0.01%	2043
2021 Q4	$89.8K	Hold	7,302	–	–	﹤0.01%	2536
2021 Q3	$133K	Buy	+7,302	New	+$80.7K	﹤0.01%	2354

Other funds holding AMTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

ECA

Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

TCM

Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s AMTX Position: Q1 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Aemetis (AMTX) in Q1 2023, closing a stake of 1,851 shares — an estimated $7.33K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AMTX in Q3 2021 and held it in 5 quarters. The position peaked at $133K in Q3 2021. 77 funds tracked by Wall St. Rank hold AMTX as of Q1 2023.

Metropolitan Life Insurance Company (MetLife) reported no remaining Aemetis position as of Q1 2023 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,851 Aemetis shares in Q1 2023, an estimated $7.33K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Aemetis in Q3 2021 and held it in 5 quarters.
Metropolitan Life Insurance Company (MetLife)'s Aemetis position peaked at $133K in Q3 2021.
77 funds tracked by Wall St. Rank held Aemetis as of Q1 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2023, filed 15 May 2023.